Lista de obras - John Maher - Dominio Público Uruguay

A circadian distribution to febrile episodes in neutropenic patients

artículo científico publicado en 1993

Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cells

artículo científico publicado en 2010

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid

artículo científico publicado en 2014

An unusual case of familial aplastic anaemia: in vitro and in vivo evidence for a multipotent progenitor responsive to G-CSF

artículo científico publicado en 1998

Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?

artículo científico publicado en 2016

Antitumor immunity: easy as 1, 2, 3 with monoclonal bispecific trifunctional antibodies?

artículo científico

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.

artículo científico publicado en 2019

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

scientific article published on 14 May 2019

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma

artículo científico publicado en 2017

CAR T-cell immunotherapy: The path from the by-road to the freeway?

artículo científico

CAR mechanics: driving T cells into the MUC of cancer

artículo científico publicado en 2009

Cancer Immunotherapy: Whence and Whither

artículo científico publicado en 2017

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer

scholarly article by John Wahba et al published November 2018 in Cancer Immunology, Immunotherapy

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

artículo científico publicado en 2021

Clinical Evaluation of ErbB-Targeted CAR T-Cells, Following Intracavity Delivery in Patients with ErbB-Expressing Solid Tumors.

artículo científico publicado en 2015

Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells

artículo científico publicado en 2014

Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancer

artículo científico publicado en 2011

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

artículo científico publicado en 2018

Cryoglobulinaemia identified by repeated analytical failure of laboratory tests

artículo científico publicado en 2014

Cytokine overproduction in healthy first degree relatives of patients with IDDM

artículo científico publicado en 1998

Dermatofibrosarcoma protuberans in a patient with X-linked agammaglobulinaemia

artículo científico publicado en 2007

Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA).

artículo científico publicado en 2014

Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer

artículo científico publicado en 2013

Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.

artículo científico publicado en 2012

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting

artículo científico publicado en 2018

ErbB-targeted CAR T-cell immunotherapy of cancer

artículo científico

Experimental and applied immunotherapy, 1st edn.

artículo científico publicado en 2011

Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.

artículo científico publicado en 2016

Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.

artículo científico publicado en 2016

Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.

artículo científico publicado en 2012

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields.

artículo científico publicado en 2017

Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?

article

Generation of human islet-specific regulatory T cells by TCR gene transfer

artículo científico publicado en 2017

Generation of hypoxia-sensing chimeric antigen receptor T cells

artículo científico publicado en 2021

Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation

article

How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit

artículo científico publicado en 2015

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

article

Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells

artículo científico publicado en 2012

Implementation of National Institute for Health and Care Excellence (NICE) guidance to measure immunoglobulin A with all coeliac screens: can an affordable solution be devised?

artículo científico publicado en 2017

In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate

scientific article published on 16 October 2018

In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.

artículo científico publicado en 2016

Increase in allergy following donor lymphocyte infusions

scientific article published on 01 May 2006

Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells.

artículo científico publicado en 2017

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

artículo científico publicado en 2017

Modulation of dendritic cell differentiation by colony-stimulating factor-1: role of phosphatidylinositol 3'-kinase and delayed caspase activation

artículo científico publicado en 2007

Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research

artículo científico publicado en 2016

Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety

article

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?

artículo científico publicado en 2013

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells

artículo científico

Prospects for combined use of oncolytic viruses and CAR T-cells

artículo científico publicado en 2017

Role of the clinical immunology laboratory in disease monitoring

scholarly article by John Maher published 2013 in World journal of immunology

Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer

artículo científico publicado en 2016

Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.

artículo científico publicado en 2010

Severe bleomycin lung toxicity: reversal with high dose corticosteroids ⬇️

artículo científico publicado el 1 de enero de 1993

Skin anergy and tuberculosis

artículo científico publicado en 1992

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin.

artículo científico publicado en 2013

TSLPR: a new CAR in the showroom for B-ALL.

artículo científico publicado en 2015

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

artículo científico publicado en 2017

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells

artículo científico publicado en 2016

The integrin αvβ6: a novel target for CAR T-cell immunotherapy?

artículo científico publicado en 2016

The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.

artículo científico publicado en 2016

The role of the HGF/Met axis in mesothelioma.

artículo científico publicado en 2016

The role of the interleukin (IL)-6/IL-6 receptor axis in cancer

scientific article published on 22 November 2018

Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice

artículo científico publicado en 2011

Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cells.

artículo científico publicado en 2011

Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?

artículo científico publicado en 2013

Use of retroviral-mediated gene transfer to deliver and test function of chimeric antigen receptors in human T-cells

article

Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells.

artículo científico

Lista de obras de John Maher

A circadian distribution to febrile episodes in neutropenic patients

Adoptive T-cell immunotherapy of cancer using chimeric antigen receptor-grafted T cells

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid

An unusual case of familial aplastic anaemia: in vitro and in vivo evidence for a multipotent progenitor responsive to G-CSF

Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?

Antitumor immunity: easy as 1, 2, 3 with monoclonal bispecific trifunctional antibodies?

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma

CAR T-cell immunotherapy: The path from the by-road to the freeway?

CAR mechanics: driving T cells into the MUC of cancer

Cancer Immunotherapy: Whence and Whither

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer

Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells

Clinical Evaluation of ErbB-Targeted CAR T-Cells, Following Intracavity Delivery in Patients with ErbB-Expressing Solid Tumors.

Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cells

Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancer

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.

Cryoglobulinaemia identified by repeated analytical failure of laboratory tests

Cytokine overproduction in healthy first degree relatives of patients with IDDM

Dermatofibrosarcoma protuberans in a patient with X-linked agammaglobulinaemia

Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA).

Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer

Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting

ErbB-targeted CAR T-cell immunotherapy of cancer

Experimental and applied immunotherapy, 1st edn.

Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.

Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.

Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields.

Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?

Generation of human islet-specific regulatory T cells by TCR gene transfer

Generation of hypoxia-sensing chimeric antigen receptor T cells

Harnessing the tumour-derived cytokine, CSF-1, to co-stimulate T-cell growth and activation

How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells

Implementation of National Institute for Health and Care Excellence (NICE) guidance to measure immunoglobulin A with all coeliac screens: can an affordable solution be devised?

In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate

In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.

Increase in allergy following donor lymphocyte infusions

Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells.

Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Modulation of dendritic cell differentiation by colony-stimulating factor-1: role of phosphatidylinositol 3'-kinase and delayed caspase activation

Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research

Pre-clinical development of chimeric antigen receptor T-cell immunotherapy: Implications of design for efficacy and safety

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?

Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells

Prospects for combined use of oncolytic viruses and CAR T-cells

Role of the clinical immunology laboratory in disease monitoring

Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer

Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.

Severe bleomycin lung toxicity: reversal with high dose corticosteroids ⬇️

Skin anergy and tuberculosis

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin.

TSLPR: a new CAR in the showroom for B-ALL.

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells

The integrin αvβ6: a novel target for CAR T-cell immunotherapy?

The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.

The role of the HGF/Met axis in mesothelioma.

The role of the interleukin (IL)-6/IL-6 receptor axis in cancer

Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice

Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cells.

Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?

Use of retroviral-mediated gene transfer to deliver and test function of chimeric antigen receptors in human T-cells

Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells.